<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39351391</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2312-0541</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>ERJ open research</Title><ISOAbbreviation>ERJ Open Res</ISOAbbreviation></Journal><ArticleTitle>Post-pandemic seasonal dynamics of hospitalised COPD exacerbations and aetiologies in the COPD population.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">00258-2024</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/23120541.00258-2024</ELocationID><Abstract><AbstractText><b>This study uncovered a reversal of seasonal variation in hospitalised COPD exacerbation events after the COVID-19 pandemic. Investigation of updated seasonal exacerbation patterns and triggers can help initiate preventive strategies effectively.</b> https://bit.ly/3wN71h0.</AbstractText><CopyrightInformation>Copyright ©The authors 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aung</LastName><ForeName>Hnin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health, NIHR Respiratory Biomedical Research Centre, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aung</LastName><ForeName>Aye</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Lung Health, NIHR Respiratory Biomedical Research Centre, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAuley</LastName><ForeName>Hamish J C</ForeName><Initials>HJC</Initials><Identifier Source="ORCID">0000-0001-8997-0764</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health, NIHR Respiratory Biomedical Research Centre, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elneima</LastName><ForeName>Omer</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-2480-8840</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health, NIHR Respiratory Biomedical Research Centre, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flynn</LastName><ForeName>Cara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0005-9326-966X</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health, NIHR Respiratory Biomedical Research Centre, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thornton</LastName><ForeName>Tracy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute for Lung Health, NIHR Respiratory Biomedical Research Centre, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Lung Health, NIHR Respiratory Biomedical Research Centre, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brightling</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health, NIHR Respiratory Biomedical Research Centre, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Adam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1621-1622</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greening</LastName><ForeName>Neil J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0003-0453-7529</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Lung Health, NIHR Respiratory Biomedical Research Centre, University Hospitals of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ERJ Open Res</MedlineTA><NlmUniqueID>101671641</NlmUniqueID><ISSNLinking>2312-0541</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest: H. Aung, A. Aung, H.J.C. McAuley, O. Elneima, C. Flynn, T. Thornton and H. Evans have no potential conflicts of interest to disclose. C.E. Brightling has received grants and consultancy fees from 4D Pharma, AstraZeneca, Chiesi, Genentech, GlaxoSmithKline, Mologic, Novartis, Regeneron Pharmaceuticals, Roche and Sanofi. A. Wright has received grant income (paid to institution) from Sanofi. N.J. Greening has received honoraria for lectures, conference travel and advisory boards from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline and Pulmonx, and received grants and consultation fees (paid to institution) from Genentech, Roche and GlaxoSmithKline.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39351391</ArticleId><ArticleId IdType="pmc">PMC11440372</ArticleId><ArticleId IdType="doi">10.1183/23120541.00258-2024</ArticleId><ArticleId IdType="pii">00258-2024</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wilkinson TMA, Aris E, Bourne S, et al. . A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. Thorax 2017; 72: 919–927. doi:10.1136/thoraxjnl-2016-209023</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2016-209023</ArticleId><ArticleId IdType="pmc">PMC5738531</ArticleId><ArticleId IdType="pubmed">28432209</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani JS, Oyelade T, Aldhahir AM, et al. . Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis. PLoS One 2021; 16: e0255659. doi:10.1371/journal.pone.0255659</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255659</ArticleId><ArticleId IdType="pmc">PMC8330941</ArticleId><ArticleId IdType="pubmed">34343205</ArticleId></ArticleIdList></Reference><Reference><Citation>Bafadhel M, McKenna S, Terry S, et al. . Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011; 184: 662–671. doi:10.1164/rccm.201104-0597OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201104-0597OC</ArticleId><ArticleId IdType="pubmed">21680942</ArticleId></ArticleIdList></Reference><Reference><Citation>Holub M, Beran O, Kaspříková N, et al. . Neutrophil to lymphocyte count ratio as a biomarker of bacterial infections. Open Med 2012; 7: 258–261. doi:10.2478/s11536-012-0002-3</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/s11536-012-0002-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev D, Wallace E, Sankaran R, et al. . Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med 1998; 92: 664–667. doi:10.1016/S0954-6111(98)90515-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0954-6111(98)90515-7</ArticleId><ArticleId IdType="pubmed">9659534</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarc I, Lotric Dolinar A, Morgan T, et al. . Mortality, seasonal variation, and susceptibility to acute exacerbation of COPD in the pandemic year: a nationwide population study. Ther Adv Respir Dis 2022; 16: 17534666221081047. doi:10.1177/17534666221081047</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17534666221081047</ArticleId><ArticleId IdType="pmc">PMC8905064</ArticleId><ArticleId IdType="pubmed">35253548</ArticleId></ArticleIdList></Reference><Reference><Citation>Seemungal T, Harper-Owen R, Bhowmik A, et al. . Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618–1623. doi:10.1164/ajrccm.164.9.2105011</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.164.9.2105011</ArticleId><ArticleId IdType="pubmed">11719299</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Kolsum U, Brightling CE, et al. . Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J 2014; 44: 1697–1700. doi:10.1183/09031936.00162414</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00162414</ArticleId><ArticleId IdType="pubmed">25323230</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Liang L, Feng L, et al. . The prognostic value of blood eosinophil level in AECOPD is influenced by corticosteroid treatment during hospitalization. J Inflamm Res 2023; 16: 3233–3243. doi:10.2147/JIR.S421605</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S421605</ArticleId><ArticleId IdType="pmc">PMC10404713</ArticleId><ArticleId IdType="pubmed">37555013</ArticleId></ArticleIdList></Reference><Reference><Citation>Aung H, McAuley H, Porter K, et al. . Differences in hospital admissions for acute exacerbations of COPD during the COVID-19 pandemic stratified by stable-state blood eosinophil count. Eur Respir J 2023; 62: 2301125. doi:10.1183/13993003.01125-2023</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01125-2023</ArticleId><ArticleId IdType="pmc">PMC10568037</ArticleId><ArticleId IdType="pubmed">37770078</ArticleId></ArticleIdList></Reference><Reference><Citation>Donaldson GC, Wedzicha JA. The causes and consequences of seasonal variation in COPD exacerbations. Int J Chron Obstruct Pulmon Dis 2014; 9: 1101–1110. doi:10.2147/COPD.S54475</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S54475</ArticleId><ArticleId IdType="pmc">PMC4199860</ArticleId><ArticleId IdType="pubmed">25336941</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Brusselen D, De Troeyer K, Ter Haar E, et al. . Bronchiolitis in COVID-19 times: a nearly absent disease? Eur J Pediatr 2021; 180: 1969–1973. doi:10.1007/s00431-021-03968-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-03968-6</ArticleId><ArticleId IdType="pmc">PMC7847293</ArticleId><ArticleId IdType="pubmed">33517482</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute for Government . Timeline of UK government coronavirus lockdowns and restrictions. Date last updated: 9 December 2022. www.instituteforgovernment.org.uk/data-visualisation/timeline-coronavirus-lockdowns</Citation></Reference><Reference><Citation>Jenkins CR, Celli B, Anderson JA, et al. . Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 2012; 39: 38–45. doi:10.1183/09031936.00194610</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00194610</ArticleId><ArticleId IdType="pubmed">21737561</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise RA, Calverley PMA, Carter K, et al. . Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR trial. Int J Chron Obstruct Pulmon Dis 2018; 13: 605–616. doi:10.2147/COPD.S148393</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S148393</ArticleId><ArticleId IdType="pmc">PMC5819585</ArticleId><ArticleId IdType="pubmed">29497289</ArticleId></ArticleIdList></Reference><Reference><Citation>So JY, Zhao H, Voelker H, et al. . Seasonal and regional variations in chronic obstructive pulmonary disease exacerbation rates in adults without cardiovascular risk factors. Ann Am Thorac Soc 2018; 15: 1296–1303. doi:10.1513/AnnalsATS.201801-070OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201801-070OC</ArticleId><ArticleId IdType="pmc">PMC6322011</ArticleId><ArticleId IdType="pubmed">30063372</ArticleId></ArticleIdList></Reference><Reference><Citation>McAuley H, Hadley K, Elneima O, et al. . COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD. ERJ Open Res 2021; 7: 00718-2020. doi:10.1183/23120541.00718-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00718-2020</ArticleId><ArticleId IdType="pmc">PMC7607968</ArticleId><ArticleId IdType="pubmed">33527075</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>